Literature DB >> 16005739

Point mutations in an infectious bovine viral diarrhoea virus type 2 cDNA transcript that yields an attenuated and protective viral progeny.

P Dehan1, B Couvreur, C Hamers, P Lewalle, E Thiry, P Kerkhofs, P-P Pastoret.   

Abstract

An infectious cDNA clone of the hypervirulent bovine viral diarrhoea virus (BVDV) strain 890 (isolate 256) was produced by a streamlined PCR procedure. As compared to the published sequence of strain 890, the nucleotide sequencing of cloned cDNA corresponding to isolate 256 revealed several mutations seven of which were attributed to the cloning procedure. The infectious transcript was transfected into permissive cells and led to viral multiplication (AvrII+ strain). In vitro, viral titres reached by the parental strain exceed those of the AvrII+ strain by more than one order of magnitude. The latter was clearly less virulent to young calves as indicated by clinical, haematological and virological parameters. Thirty-four days after inoculation with AvrII+ strain, calves were challenged with the virulent parental strain. The animals were protected as compared to unvaccinated controls. Therefore, our approach led to the production of an attenuated strain with potential use as a vaccine strain and will be useful for studies of virulence determinants in BVDV-2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16005739     DOI: 10.1016/j.vaccine.2005.03.026

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  2 in total

1.  Regeneration and characterization of a recombinant bovine viral diarrhea virus and determination of its efficacy to cross the bovine placenta.

Authors:  Zhen-Chuan Fan; Hai-Hong Wang
Journal:  Virus Genes       Date:  2008-12-09       Impact factor: 2.332

2.  Use of homologous recombination in yeast to create chimeric bovine viral diarrhea virus cDNA clones.

Authors:  Sandra Arenhart; José Valter Joaquim Silva; Eduardo Furtado Flores; Rudi Weiblen; Laura Helena Vega Gonzales Gil
Journal:  Braz J Microbiol       Date:  2016-07-26       Impact factor: 2.476

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.